Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

<< Previous

Bullboard Posts

Next >>

Post by canadafanon May 29, 2023 11:40am

356 Views

Post# 35468777

Nice recovery today on TSX…

Nice recovery today on TSX.
First, no Nas open today AKA shorting manipulation.
Second...I have seen this many times.

A longer build- up prenews, then on day of news,a sell- off.
Giving the news time to sink in, those who take the time. Relize the depth & importance of the news, Up it goes.
Anyone who understands, knows full well there will be additional & stringer evidence being presented this coming Saturday.
A week from now, KOL open mic etc. That will be premarket.
Giving time for what ever is presented to be explained & sink in.
The Onc story is 25+ years old. My read , we are in the final chapter.
Wait times are now into weeks. No longer quarters or months.
Have a great week all.